---
layout: minimal-medicine
title: Phytomenadione (Vitamin K1)
---

# Phytomenadione (Vitamin K1)
### Generic Name
Phytomenadione (Vitamin K1)

### Usage

Phytomenadione, commonly known as vitamin K1, plays a crucial role in blood clotting.  Its primary use is in preventing and treating vitamin K deficiency, which can lead to bleeding problems. This deficiency can arise from various causes, including inadequate dietary intake, malabsorption issues (like in celiac disease or cystic fibrosis), or use of certain medications (especially anticoagulants like warfarin).  

Phytomenadione is used to treat conditions resulting in vitamin K deficiency such as:

* **Hypoprothrombinemia:**  A condition characterized by low levels of prothrombin, a crucial clotting factor.  This can manifest as increased bleeding tendency.
* **Hemorrhagic disease of the newborn:** A condition in newborns where inadequate vitamin K levels lead to bleeding complications.  Prophylactic doses are often given to newborns to prevent this.
* **Treatment of bleeding associated with Vitamin K antagonist therapy:**  Vitamin K is used to reverse the anticoagulant effects of drugs like warfarin in case of excessive bleeding or the need for urgent surgery.  However, routine use for INR management is not recommended.

### Dosage

Dosage varies significantly depending on the condition being treated, the patient's age, and the route of administration (oral, intramuscular (IM), subcutaneous (SubQ), or intravenous (IV)).

**Adults:**

* **Nutritional supplementation:**  The recommended daily allowance varies based on gender (men: 120 mcg; women: 90 mcg).  This is generally achieved through a balanced diet.
* **Hypoprothrombinemia:** Dosages range from 2.5 mg to 25 mg, depending on severity, administered orally, SubQ, IM, or IV.
* **Warfarin reversal (off-label):**  Dosage depends on the INR (International Normalized Ratio) level and the presence of bleeding.  Lowering or holding the warfarin dose along with frequent INR monitoring is usually the initial approach.  Oral doses of 2.5-5 mg or higher might be used in cases of significantly elevated INR and bleeding. In case of major bleeding, higher doses of Vitamin K along with four-factor prothrombin complex concentrate (PCC) might be necessary. For routine warfarin users undergoing procedures, a dose of 1-2.5 mg may be given the day before surgery.


**Children:**

* **Nutritional supplementation:** Daily intake recommendations vary by age (see details provided in the source material).
* **Hemorrhagic disease of the newborn (prevention):** 0.5-1 mg IM within one hour of birth is common, possibly higher doses if the mother received anticoagulants.
* **Warfarin reversal (off-label):** Dosage in children is generally calculated based on weight (0.03 mg/kg, with a maximum of 1 mg) and given intravenously; however, this usually accompanies additional measures such as fresh frozen plasma or other clotting factors.

**Dosage Adjustments:**  No specific dosage adjustments are generally recommended for hepatic or renal impairment based on manufacturer's labels.

### Side Effects

Common side effects are rare and usually mild, occurring in less than 1% of patients:

* Transient flushing
* Hypotension
* Cyanosis
* Dizziness
* Pain at injection site
* Abnormal taste
* Gastrointestinal upset
* Hemolysis (rare)
* Dyspnea
* Diaphoresis
* Anaphylaxis (rare but serious)
* Hypersensitivity reactions


**Serious side effects,** while uncommon, can include severe allergic reactions like anaphylaxis.  **Any adverse effects should be reported to a healthcare professional immediately.**


### How it Works

Phytomenadione is essential for the liver to produce several clotting factors (II, VII, IX, and X). These factors are vital components of the coagulation cascade, a series of reactions that ultimately lead to blood clot formation and stop bleeding.  By acting as a cofactor in this process, vitamin K1 ensures proper blood clotting.


### Precautions

* **Hypersensitivity:** Individuals with a known allergy to phytomenadione or any components of its formulation should avoid it.
* **IV and IM administration:**  Rapid IV or IM injection carries a significant risk of severe reactions, including death, and should only be used when other routes are not feasible.
* **Newborns:**  Caution is advised, particularly in premature infants due to the risk of hemolytic anemia, jaundice, and hyperbilirubinemia.
* **Patients with hypoprothrombinemia:**  Careful monitoring is necessary when administering vitamin K to patients with pre-existing bleeding disorders or those on anticoagulants.
* **Drug Interactions:**  Vitamin K can interact with anticoagulants like warfarin, potentially reducing their effectiveness. Close monitoring of INR is crucial when administering Vitamin K to patients on warfarin.
* **Pregnancy and Lactation:**  Phytomenadione falls under Pregnancy Category C.  Use during pregnancy and lactation should only be considered when the benefits clearly outweigh the potential risks. Excretion in breast milk is not fully characterized.



### FAQs

* **Can I take Phytomenadione with food?** It can be taken without regard to food.
* **What should I do if I experience bleeding while taking this medication?** Report any unusual bleeding (e.g., bleeding gums, blood in urine or stool, easy bruising) to your doctor immediately.
* **How should I store Phytomenadione?** Store according to the manufacturer's instructions, usually at room temperature away from direct sunlight and moisture.
* **Can I stop taking Phytomenadione if I feel better?**  Do not discontinue the medication without consulting your doctor, as stopping treatment prematurely may lead to recurrence of bleeding complications.
* **Is Phytomenadione addictive?** No, phytomenadione is not addictive.


**Disclaimer:**  This information is intended for educational purposes only and should not be considered medical advice. Always consult with a healthcare professional for any health concerns or before starting, stopping, or altering any treatment.  This information is based on the provided source material and may not encompass all available information or address all possible variations in use or dosage.
